Critical Care of Acute Ischemic Stroke

Critical Care Clinics

Volumn 22, Issue 4, 2006, Pages 581-606

  Finley Caulfield, Anna ^a   Wijman, Christine A C ^a  

^a Stanford Medicine Children s Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CRITICAL CARE; HUMANS;

EID: 33846263013     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2006.09.001     Document Type: Review

References (139)

1. American Heart Association. Heart disease and stroke statistics: 2006-update (2006), American Heart Association, Dallas (TX)
2. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 333 (1995) 1581-1587
3. Kalafut M.A., and Saver J.L. The acute stroke patient: the first six hours. In: Cohen S.N. (Ed). Management of ischemic stroke (2000), McGraw-Hill, New York 17-52
4. Becker K. Intensive care unit management of the stroke patient. Neurol Clin 18 (2000) 439-454
5. Daniels S.K., Brailey K., Priestly D.H., et al. Aspiration in patients with acute stroke. Arch Phys Med Rehabil 79 (1998) 14-19
6. Gujjar A.R., Diebert E., Manno E.M., et al. Mechanical ventilation for ischemic stroke and intracerebral hemorrhage: indications, timing, and outcome. Neurology 51 (1998) 447-451
7. Wijdicks E.F., and Scott J.P. Outcome in patients with acute basilar artery occlusion requiring mechanical ventilation. Stroke 27 (1996) 1301-1303
8. Mirski M.A., Muffelman B., Ulatowski J.A., et al. Sedation for the critically ill neurologic patient. Crit Care Med 23 (1995) 2038-2053
9. Shibutani T., Hirota Y., Niwa H., et al. Cerebral arterial blood flow velocity during induction of general anesthesia: rapid intravenous induction versus awake intubation. Anesth Prog 40 (1993) 122-126
10. Burchiel K.J., Steege T.D., and Wyler A.R. Intracranial pressure changes in brain-injured patients requiring positive end-expiratory pressure ventilation. Neurosurgery 8 (1981) 443-449
11. Cooper K.R., Boswell P.A., and Choi S.C. Safe use of PEEP in patients with severe head injury. J Neurosurg 63 (1985) 552-555
12. Knudsen L., Cold G.E., Holdgard H.O., et al. The effects of midazolam on cerebral blood flow and oxygen consumption: interaction with nitrous oxide in patients undergoing craniotomy for supratentorial tumors. Anaesthesia 45 (1990) 1016-1019
13. Papazian L., Albanese J., Thirion X., et al. Effect of bolus doses of midazolam on intracranial pressure and cerebral perfusion pressure in patients with severe head injury. Br J Anaesth 71 (1993) 267-271
14. Albanese J., Viviand X., Potie F., et al. Sufentanil, fentanyl, and alfentanil in head trauma patients: a study on cerebral hemodynamics. Crit Care Med 27 (1999) 262-263
15. Kumar M.A., Urrutia V.C., Thomas C.E., et al. The syndrome of irreversible acidosis after prolonged propofol infusion. Neurocrit Care 3 (2005) 257-259
16. Paulson O.B., Strandgaard S., and Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev 2 (1990) 161-192
17. Sugimori H., Ibayashi S., Fujii K., et al. Brain infarction developed in hypertensive and normotensive patients during hospitalization-hemodynamic factors. Angiology 46 (1995) 473-480
18. Strandgaard S. Autoregulation of cerebral blood flow in hypertensive patients: the modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension. Circulation 53 (1976) 720-727
19. Powers W.J. Acute hypertension after stroke: the scientific basis for treatment decisions. Neurology 43 3 Pt 1 (1993) 461-467
20. Meyer J.S., Shimazu K., Fukuuchi Y., et al. Impaired neurogenic cerebrovascular control and dysautoregulation after stroke. Stroke 4 (1973) 169-186
21. Adams H., Adams R., Del Zoppo G., et al. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update-a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 36 (2005) 916-923
22. Brott T., Lu M., Kothari R., et al. Hypertension and its treatment in the NINDS rt-PA stroke trial. Stroke 29 (1998) 1504-1509
23. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for acute ischemic stroke. Stroke 28 (1997) 2109-2118
24. Adams H.P., Robert J., Adams R.J., et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 34 (2003) 1056-1083
25. Cottrell J.E., Patel K., Turndorf H., et al. Intracranial pressure changes induced by sodium nitroprusside in patients with intracranial mass lesions. J Neurosurg 48 (1978) 329-331
26. Schroeder T., and Sillesen H. Dihydralazine induces marked cerebral vasodilation in man. Eur J Clin Invest 17 (1987) 214-217
27. Skinhoj E., and Overgaard J. Effect of dihydralazine on intracranial pressure in patients with severe brain damage. Acta Med Scand 678 Suppl (1983) 83-87
28. Nazir F.S., Overell J.R., Bolster A., et al. Effect of perindopril on cerebral and renal perfusion on normotensives in mild early ischaemic stroke: a randomized controlled trial. Cerebrovasc Dis 19 (2005) 77-83
29. Tohmo H., and Karanko M. Enalaprilat controls postoperative hypertension while maintaining cardiac function and systemic oxygenation after neurosurgery. Intensive Care Med 21 (1995) 651-656
30. Hillis A.E., Ulatowski J.A., Barker P.B., et al. A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke. Cerebrovasc Dis 16 (2003) 236-246
31. White O.B., Norris J.W., Hachinski V.C., et al. Death in early stroke: causes and mechanisms. Stroke 10 (1979) 743
32. Adams Jr. H.P., Brott T.G., Furlan A.J., et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke-a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke 27 (1996) 1711-1718
33. Practice advisory: thrombolytic therapy for acute ischemic stroke-summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 47 (1996) 835-839
34. Johnston K.C., and Haley Jr. E.C. Emergency imaging of the acute stroke patient. J Neuroimaging 7 (1997) 111-117
35. Truwit C.L., Barkovich A.J., Gean-Marton A., et al. Loss of the insular ribbon: another early CT sign of acute middle cerebral artery infarction. Radiology 176 (1990) 801-806
36. Moulin T., Cattin F., Crepin-Leblond T., et al. Early CT signs in acute middle cerebral artery infarction: predictive value for subsequent infarct locations and outcome. Neurology 47 (1996) 366-375
37. Patel S.C., Levine S.R., Tilley B.C., et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. JAMA 286 (2001) 2830-2838
38. Morgenstern L.B., Luna-Gonzales H., Huber Jr. J.C., et al. Worst headache and subarachnoid hemorrhage: prospective, modern computed tomography and spinal fluid analysis. Ann Emerg Med 32 3 Pt 1 (1998) 297-304
39. Hunter G.J., Hamberg L.M., Ponzo J.A., et al. Assessment of cerebral perfusion and arterial anatomy in hyperacute stroke with three-dimensional functional CT: early clinical results. AJNR Am J Neuroradiol 19 (1998) 29-37
40. Josephson S.A., Dillon W.P., and Smith W.S. Incidence of contrast nephropathy from cerebral CT angiography and CT perfusion imaging. Neurology 64 (2005) 1805-1806
41. Kidwell C.S., and Hsia A.W. Imaging of the brain and cerebral vasculature in patients with suspected stroke: advantages and disadvantages of CT and MRI. Curr Neurol Neurosci Rep 6 (2006) 9-16
42. Wintermark M., Reichhart M., Thiran J.P., et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 51 (2002) 417-432
43. Shuaib A., Lee D., Pelz D., et al. The impact of magnetic resonance imaging on the management of acute ischemic stroke. Neurology 42 (1992) 816-818
44. Lutsep H.L., Albers G.W., DeCrespigny A., et al. Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol 41 (1997) 574-580
45. Tong D.C., Yenari M.A., Albers G.W., et al. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (< 6.5 hour) ischemic stroke. Neurology 50 (1998) 864-870
46. Warach S., Gaa J., Siewert B., et al. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 37 (1995) 231-241
47. Willig D.S., Turski P.A., Frayne R., et al. Contrast-enhanced 3D MR DSA of the carotid artery bifurcation: preliminary study of comparison with unenhanced 2D and 3D time-of-flight MR angiography. Radiology 208 (1998) 447-451
48. Remonda L., Heid O., and Schroth G. Carotid artery stenosis, occlusion, and pseudo-occlusion: first-pass, gadolinium-enhanced, three-dimensional MR angiography-preliminary study. Radiology 209 (1998) 95-102
49. Siewert B., Schlaug G., Edelman R.R., et al. Comparison of EPISTAR and T2*-weighted gadolinium-enhanced perfusion imaging in patients with acute cerebral ischemia. Neurology 48 (1997) 673-679
50. Warach S., Dashe J.F., and Edelman R.R. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab 16 (1996) 53-59
51. Albers G.W., Thijs V.N., Wechsler L., et al. Results of the Diffusion-weighted imaging Evaluation For Understanding Stroke Evolution (DEFUSE) study. DEFUSE investigators. Stroke 37 (2006) 635
52. Albers G.W., Amarenco P., Easton J.D., et al. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 3 Suppl (2004) 483S-512S
53. The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 28 (1997) 2119-2125
54. Haley Jr. E.C., Lewandowski C., and Tilley B.C. Myths regarding the NINDS rt-PA Stroke Trial: setting the record straight. Ann Emerg Med 30 (1997) 676-682
55. Albers G.W., Bates V.E., Clark W.M., et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 283 (2000) 1145-1150
56. Hill M.D., and Buchan A.M. Methodology for the Canadian Activase for Stroke Effectiveness Study (CASES). CASES investigators. Can J Neurol Sci 28 (2001) 232-238
57. Hacke W., Kaste M., Fieschi C., et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274 (1995) 1017-1025
58. Hacke W., Kaste M., Fieschi C., et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 352 (1998) 1245-1251
59. Clark W.M., Albers G.W., Madden K.P., et al. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Thrombolytic therapy in acute ischemic stroke study investigators. Stroke 31 (2000) 811-816
60. Randomized controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial-Italy (MAST-I) Group. Lancet 346 (1995) 1509-1514
61. Thrombolytic therapy with streptokinase in acute ischemic stroke. The Multicenter Acute Stroke Trial-Europe Study Group. N Engl J Med 335 (1996) 145-150
62. Donnan G.A., Davis S.M., Chambers B.R., et al. Streptokinase for acute ischemic stroke with relationship to time of administration. Australian Streptokinase (ASK) Trial Study Group. JAMA 276 (1996) 961-966
63. Ancrod for the treatment of acute ischemic brain infarction. The Ancrod Stroke Study investigators. Stroke 25 (1994) 1755-1759
64. Levy DE. Ancrod in stroke program ASP I: ancrod (viprinex) for the treatment of acute, ischemic stroke. American Stroke Association International Conference Ongoing Trials Abstracts, February 16, 2006:CTP8.
65. Sherman D.G., Atkinson R.P., Chippendale T., et al. Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial. JAMA 283 (2000) 2395-2403
66. Furlan A.J., Eyding D., Albers G.W., et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 37 (2006) 1227-1231
67. Hacke W., Albers G., Al-Rawi Y., et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36 (2005) 66-73
68. Abciximab Emergent Stroke Treatment Trial (AbESTT) investigators. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial. Stroke 36 (2005) 880-890
69. Pancioli A. The combined approach to lysis utilizing eptifibatide and rtPA in acute ischemic stroke (the CLEAR Stroke Trial): blinded results tier I and II. American Stroke Association International Conference Ongiong Trials Abstracts, February 16, 2006:CTP17.
70. Warach S, Butman J, Davis L. Reopro Retavase reperfusion of stroke safety study-imaging evaluation (ROSIE): interim safety and efficacy results. The ROSIE Investigators. American Stroke Association International Conference late breaking science oral abstracts, February 18, 2006.
71. del Zoppo G.J., Higashida R.T., Furlan A.J., et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 29 (1998) 4-11
72. Furlan A., Higashida R., Wechsler L., et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282 (1999) 2003-2011
73. The IMS study investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke study (IMS). Stroke 35 (2004) 904-912
74. Molina C.A., and Saver J.L. Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies. Stroke 36 (2005) 2311-2320
75. Berlis A., Lutsep H., Barnwell S., et al. Mechanical thrombolysis in acute ischemic stroke with endovascular photoacoustic recanalization. Stroke 35 (2004) 1112-1116
76. Wikholm G. Transarterial embolectomy in acute stroke. AJNR Am J Neuroradiol 24 (2003) 892-894
77. Mayer T.E., Hamann G.F., and Brueckmann H.J. Treatment of basilar artery embolism with a mechanical extraction device: necessity of flow reversal. Stroke 33 (2002) 2232-2235
78. Smith W.S., Sung G., Starkman S., et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36 (2005) 1432-1438
79. Ringer A.J., Qureshi A.I., Fessler R.D., et al. Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke. Neurosurgery 48 (2001) 1282-1288
80. Leary M.C., Saver J.L., Gobin Y.P., et al. Beyond tissue plasminogen activator: mechanical intervention in acute stroke. Ann Emerg Med 41 (2003) 838-846
81. Nesbit G.M., Luh G., Tien R., et al. New and future endovascular treatment strategies for acute ischemic stroke. J Vasc Interv Radiol 15 1 Pt 2 (2004) S103-S110
82. Busto R., Dietrich W.D., Globus M.Y., et al. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab 7 (1987) 729-738
83. Ginsberg M.D., and Busto R. Combating hyperthermia in acute stroke: a significant clinical concern. Stroke 29 (1998) 529-534
84. Ginsberg M.D. Adventures in the pathophysiology of brain ischemia: penumbra, gene expression, neuroprotection: the 2002 Thomas Willis Lecture. Stroke 34 (2003) 214-223
85. De Georgia M.A., Krieger D.W., Abou-Chebl A., et al. Cooling for Acute Ischemic brain Damage (COOL AID): a feasibility trial of endovascular cooling. Neurology 63 (2004) 312-317
86. Guluma K.Z., Hemmen T.M., Olsen S.E., et al. A trial of therapeutic hypothermia via endovascular approach in awake patients with acute ischemic stroke: methodology. Acad Emerg Med 13 (2006) 820-827
87. Lees K.R., Zivin J.A., Ashwood T., et al. NXY-059 for acute stroke. SAINT I investigators. N Engl J Med 354 (2006) 588-600
88. Shuaib A, Davalos A, Davis SM, et al. SAINT II: design of a double-blind, multicenter, placebo-controlled study to assess the efficacy and safety of NXY-059 in acute ischemic stroke. SAINT II investigators. American Stroke Association International Conference Ongoing Trials Abstracts, February 16, 2006:CTP 7.
89. Saver JL, Eckstein M, Stratton S, et al. The field administration of stroke therapy-magnesium (FAST-MAG) phase 3 clinical trial. FAST-MAG trial investigators. American Stroke Association International Conference Ongoing Trials Abstracts, February 16, 2006:CTP 35.
90. Ginsberg M.D., Hill M.D., Palesch Y.Y., et al. The ALIAS Pilot Trial: a dose escalation and safety study of albumin therapy for acute ischemic stroke-I: physiologic responses and safety results. Stroke 37 (2006) 2100-2106
91. Palesch Y.Y., Hill M.D., Ryckborst K.J., et al. The ALIAS Pilot Trial: a dose escalation and safety study of albumin therapy for acute ischemic stroke-II: neurologic outcome and efficacy analysis. Stroke 37 (2006) 2107-2114
92. CAST. Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 349 (1997) 1641-1649
93. The International Stroke Trial (IST). A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 349 (1997) 1569-1581
94. Gubitz G., Counsell C., Sandercock P., et al. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev 2 (2000) CD000024
95. Duke R.J., Bloch R.F., Turpie A.G., et al. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. Ann Intern Med 105 (1986) 825-828
96. Bath P.M., Lindenstrom E., Boysen G., et al. Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial. Lancet 358 (2001) 702-710
97. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) investigators. JAMA 279 (1998) 1265-1272
98. Kay R., Wong K.S., Yu Y.L., et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 333 (1995) 1588-1593
99. Hommel M. Fraxiparine in Ischaemic Stroke Study. FISS bis investigators group. [abstract]. Cerebrovasc Dis 8 (1998) 11
100. Wong LKS, Chen C, Ng PW, et al. Different effects of low-molecular weight heparin on acute ischemic stroke patient with or without large artery occlusive disease. American Stroke Association International Stroke Conference Late-Breaking Oral Science Abstracts, February 18, 2006.
101. Hacke W., Donnan G., Fieschi C., et al. Association of outcome with early stroke treatment: pooled analysis of the ATLANTIS, ECASS, and NINDS rt-PA stroke trials. ATLANTIS Trial Investigators; ECASS Trial Investigators; NINDS rt-PA Study Group Investigators. Lancet 363 (2004) 768-774
102. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Stroke 28 (1997) 2109-2118
103. Hill M.D., Buchan A.M., and for the Canadian Alteplase for Stroke Effectiveness Study (CASES) investigators. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. Can Med Assoc J 172 (2005) 1307-1312
104. Tanne D., Kasner S.E., Demchuk A.M., et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 105 (2002) 1679-1685
105. Larrue V., von Kummer R., del Zoppo G., et al. Hemorrhagic transformation in acute ischemic stroke: potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 28 (1997) 957-960
106. Demchuk A.M., Morgenstern L.B., Krieger D.W., et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 30 (1999) 34-39
107. Jaillard A., Cornu C., Durieux A., et al. Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. Stroke 30 (1999) 1326-1332
108. Barber P.A., Demchuk A.M., Zhang J., et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 355 (2000) 1670-1674
109. Dubey N., Bakshi R., Wasay M., et al. Early computed tomography hypodensity predicts hemorrhage after intravenous tissue plasminogen activator in acute ischemic stroke. J Neuroimaging 11 (2001) 184-188
110. Kase C.S., Furlan A.J., Wechsler L.R., et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 57 (2001) 1603-1610
111. Larrue V., von Kummer R., Muller A., et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 32 (2001) 438-441
112. Gilligan A.K., Markus R., Read S., et al. Baseline blood pressure but not early computed tomography changes predicts major hemorrhage after streptokinase in acute ischemic stroke. Stroke 33 (2002) 2236-2242
113. Ribo M., Montaner J., Molina C.A., et al. Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator. Stroke 35 (2004) 2123-2127
114. Badjatia N., and Rosand J. Intracerebral hemorrhage. Neurologist 11 (2005) 311-324
115. Frank J.I. Large hemispheric infarction, deterioration, and intracranial pressure. Neurology 45 (1995) 1286-1290
116. Ropper A.H. Syndrome of transtentorial herniation: is vertical displacement necessary?. J Neurol Neurosurg Psychiatry 56 (1993) 932-935
117. Schneider G.H., von Helden G.H., Franke R., et al. Influence of body position on jugular venous oxygen saturation, intracranial pressure and cerebral perfusion pressure. Acta Neurochir Suppl (Wien) 59 (1993) 107-112
118. Wojner-Alexander A.W., Garami Z., Chernyshev O.Y., et al. Heads down: flat positioning improves blood flow velocity in acute ischemic stroke. Neurology 64 (2005) 1354-1357
119. Qureshi A.I., Suarez J.I., Bhardwaj A., et al. Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: effect on intracranial pressure and lateral displacement of the brain. Crit Care Med 26 (1998) 440-446
120. Paczynski R.P., He Y.Y., Diringer M.N., et al. Multiple-dose mannitol reduces brain water content in a rat model of cortical infarction. Stroke 28 (1997) 1437-1443
121. Qureshi A.I., Wilson D.A., and Traystman R.J. Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline. Neurosurgery 44 (1999) 1055-1063
122. Diringer M.N., and Zazulia A.R. Osmotic therapy: fact and fiction. Neurocrit Care 1 (2004) 219-233
123. Toung T.J., Chang Y., and Bhardwaj A. Increases in lung and brain water following experimental stroke: effect of mannitol and hypertonic saline. Crit Care Med 33 (2005) 203-208
124. Battison C., Andrews P.J., Graham C., et al. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med 33 (2005) 196-202
125. Norris J.W., and Hachinski V.C. High dose steroid treatment in cerebral infarction. BMJ (Clin Res Educ) 292 (1986) 21-23
126. Wijman C.A.C. Can we predict massive space-occupying edema in large hemispheric infarction?. Stroke 34 (2003) 1899-1900
127. Rieke K., Schwab S., Krieger D., et al. Decompressive surgery in space-occupying hemispheric infarction: results of an open, prospective trial. Crit Care Med 23 (1995) 1576-1587
128. Schwab S., Steiner T., Aschoff A., et al. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 29 (1998) 1888-1893
129. Collaborative overview of randomised trials of antiplatelet therapy: III. reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration. BMJ 308 (1994) 235-246
130. Pulsinelli W.A., Waldman S., Rawlinson D., et al. Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology 32 (1982) 1239-1246
131. Bruno A., Biller J., Adams Jr. H.P., et al. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) investigators. Neurology 52 (1999) 280-284
132. Berger L., and Hakim A.M. The association of hyperglycemia with cerebral edema in stroke. Stroke 17 (1986) 865-871
133. Broderick J.P., Hagen T., Brott T., et al. Hyperglycemia and hemorrhagic transformation of cerebral infarcts. Stroke 26 (1995) 484-487
134. Scott J.F., Robinson G.M., French J.M., et al. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke 30 (1999) 793-799
135. Busija D.W., Leffler C.W., and Pourcyrous M. Hyperthermia increases cerebral metabolic rate and blood flow in neonatal pigs. Am J Physiol 255 2 Pt 2 (1988) H343-H346
136. Reith J., Jorgensen H.S., Pedersen P.M., et al. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 347 (1996) 422-425
137. Castillo J., Davalos A., and Noya M. Progression of ischaemic stroke and excitotoxic aminoacids. Lancet 349 (1997) 79-83
138. Castillo J., Davalos A., Marrugat J., et al. Timing for fever-related brain damage in acute ischemic stroke. Stroke 29 (1998) 2455-2460
139. Castillo J., Davalos A., and Noya M. Aggravation of acute ischemic stroke by hyperthermia is related to an excitotoxic mechanism. Cerebrovasc Dis 9 (1999) 22-27